Optimal stage duration in dobutamine stress echocardiography

Area of Science:

• Cardiovascular Physiology
• Echocardiography
• Pharmacodynamics

Background:

• Dobutamine stress echocardiography (DSE) protocols vary, including stage duration.
• Dobutamine's pharmacodynamics may be influenced by varying stage lengths.
• Understanding optimal DSE protocols is crucial for accurate cardiac assessment.

Purpose of the Study:

• To compare the hemodynamic and echocardiographic effects of 5-minute versus 3-minute stages in dobutamine stress echocardiography.
• To determine if longer DSE stages yield different cardiovascular responses.
• To assess the benefit of extended stage duration in DSE protocols.

Main Methods:

• Paired dobutamine stress echocardiograms were performed in 10 instrumented dogs.
• Stage duration was randomly assigned to 3 or 5 minutes, with baseline recovery between tests.
• Hemodynamic (heart rate, blood pressure, coronary flow) and echocardiographic (wall thickness, cavity area) variables were recorded.

Main Results:

• No baseline differences were observed between 3- and 5-minute protocols.
• A 5-minute stage resulted in greater increases in heart rate, blood pressure, and coronary flow at a 10 mcg/kg/min dobutamine dose.
• DSE endpoints were reached at a significantly lower peak dobutamine dose with the 5-minute stage (11.0 ± 2.1 mcg/kg/min) compared to the 3-minute stage (15.0 ± 4.1 mcg/kg/min).

Conclusions:

• Longer dobutamine stress echocardiography stages (5 min) elicit greater hemodynamic effects at lower peak dobutamine doses in a canine model.
• Extending DSE stage duration may allow for achieving equivalent physiologic stress with reduced medication.
• This finding supports optimizing clinical dobutamine stress echocardiography protocols through adjusted stage durations.